Bacteriophage Therapy for Difficult-to-Treat Infections: The Implementation of a Multidisciplinary Phage Task Force...

Area of Science:

• Microbiology
• Infectious Diseases
• Drug Discovery

Background:

• Antimicrobial resistance is a growing global health crisis, limiting treatment options for chronic infections.
• Bacteriophage (phage) therapy is a promising alternative, but clinical implementation faces hurdles.
• Limited clinical trials and inconsistent application protocols hinder phage therapy's widespread adoption.

Purpose of the Study:

• To present a study protocol designed to overcome current limitations in phage therapy.
• To establish optimal application protocols, understand systemic effects, and standardize phage selection and combination.
• To generate reliable safety and efficacy data for phage therapy through a multidisciplinary approach.

Main Methods:

• A multidisciplinary approach integrating clinical, pharmaceutical, and molecular microbiology expertise.
• Development of a standardized protocol addressing administration route, frequency, duration, and phage titer.
• Focus on systematic evaluation of phage selection, cocktail formulation, and systemic effects.

Main Results:

• This section will detail the outcomes of the implemented study protocol once data are collected.
• Anticipated results include standardized phage therapy guidelines and robust safety/efficacy data.
• The study aims to provide evidence-based insights into optimizing phage therapy.

Conclusions:

• This protocol addresses critical scientific hurdles impeding clinical phage therapy.
• The multidisciplinary approach will yield standardized, reliable data on phage therapy safety and efficacy.
• Successful implementation is expected to advance the clinical use of bacteriophages against resistant infections.